Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
FDA guidelines state that they should only be prescribed to people with a BMI (body mass index) over 30kg/m, or a BMI over 27kg/mwith a weight-related medical condition
Several national healthcare systems, including those in Germany and the U.K., are expanding reimbursement eligibility for GLP-1 therapies within targeted patient groups
What is step therapy
Some GLP-1 medications may be covered under Part D when prescribed for certain other medical conditions, such as diabetes or other approved indications, but coverage for obesity alone has been limited
[9] [11] For weight management, semaglutide is available as Wegovy in the UK, not Ozempic
Every treatment plan is personalized based on a child's medical history, metabolic health, growth, and long-term goals
